Open Orphan said it had agreed to acquire fellow pharmaceutical services provider hVIVO by means of a share-based reverse takeover valuing the business at about...
Healthcare investor Syncona said portfolio company Autolus Therapeutics had released data showing progress on a treatment for types of lymphoma and leukemia.